MY101847A - Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof. - Google Patents

Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof.

Info

Publication number
MY101847A
MY101847A MYPI87001736A MYPI19871736A MY101847A MY 101847 A MY101847 A MY 101847A MY PI87001736 A MYPI87001736 A MY PI87001736A MY PI19871736 A MYPI19871736 A MY PI19871736A MY 101847 A MY101847 A MY 101847A
Authority
MY
Malaysia
Prior art keywords
composition
pharmaceutical preparations
solid pharmaceutical
active vitamins
preparation
Prior art date
Application number
MYPI87001736A
Other languages
English (en)
Inventor
Suzuki Yoshiki
Makino Yuji
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of MY101847A publication Critical patent/MY101847A/en

Links

Classifications

    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P72/00—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof
    • H10P72/04—Apparatus for manufacture or treatment
    • H10P72/0446—Apparatus for mounting on conductive members, e.g. leadframes or conductors on insulating substrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P72/00—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof
    • H10P72/30—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for conveying, e.g. between different workstations
    • H10P72/32—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for conveying, e.g. between different workstations between different workstations
    • H10P72/3202—Mechanical details, e.g. rollers or belts
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10P—GENERIC PROCESSES OR APPARATUS FOR THE MANUFACTURE OR TREATMENT OF DEVICES COVERED BY CLASS H10
    • H10P72/00—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof
    • H10P72/70—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for supporting or gripping
    • H10P72/78—Handling or holding of wafers, substrates or devices during manufacture or treatment thereof for supporting or gripping using vacuum or suction, e.g. Bernoulli chucks

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
MYPI87001736A 1983-02-22 1987-09-18 Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof. MY101847A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58026898A JPS59155309A (ja) 1983-02-22 1983-02-22 活性型ビタミンｄ↓３類組成物

Publications (1)

Publication Number Publication Date
MY101847A true MY101847A (en) 1992-01-31

Family

ID=12206053

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87001736A MY101847A (en) 1983-02-22 1987-09-18 Composition for solid pharmaceutical preparations of active vitamins d 3 and process for preparation thereof.

Country Status (7)

Country Link
US (1) US4729895A (2)
EP (1) EP0116755B1 (2)
JP (1) JPS59155309A (2)
KR (1) KR880001095B1 (2)
DE (1) DE3372845D1 (2)
HK (1) HK86588A (2)
MY (1) MY101847A (2)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62149619A (ja) * 1985-09-05 1987-07-03 Teijin Ltd 活性型ビタミンｄ３類注射用組成物
GB8624628D0 (en) * 1986-10-14 1986-11-19 Scras Soluble/splitable tablets
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
EP0390930B1 (en) 1988-09-26 1993-03-03 Teijin Limited Stable aqueous preparation of active vitamin d 3
JP2525478B2 (ja) * 1989-03-01 1996-08-21 帝人株式会社 安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤
US5258375A (en) * 1989-03-13 1993-11-02 Ss Pharmaceutical Co., Ltd. Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate
JP2845342B2 (ja) * 1990-04-28 1999-01-13 大正製薬株式会社 ビタミンｄ▲下３▼誘導体含有固形製剤組成物
JPH04198129A (ja) * 1990-11-28 1992-07-17 Sumitomo Pharmaceut Co Ltd 活性型ビタミンｄ↓３類含有組成物
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
DK0508756T3 (da) * 1991-04-09 1997-03-24 Takeda Chemical Industries Ltd Stabiliseret vitamin D-præparat
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
WO1997011703A1 (en) * 1995-09-28 1997-04-03 Teijin Limited Preventive or remedy for hyperthyreosis
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
KR100688618B1 (ko) * 2001-09-12 2007-03-09 주식회사 유유 비타민 ｄ 경구투여용 서방성 약제 조성물
WO2007019418A1 (en) * 2005-08-08 2007-02-15 Sun Chemical Corporation Ir-luminescent nanocomposite pigment and sol-gel process for manufacturing thereof
US20070122477A1 (en) * 2005-10-12 2007-05-31 Cytochroma, Inc. Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
CA2882048C (en) 2006-02-03 2020-03-24 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
CA2587805C (en) * 2007-04-25 2014-02-18 The Procter & Gamble Company Improved vitamin d content uniformity in pharmaceutical dosage forms
CA2684778C (en) * 2007-04-25 2017-09-05 Cytochroma Inc. Methods and compounds for vitamin d therapy
ES2401205T3 (es) * 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
WO2009047644A2 (en) * 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
CA2683514C (en) 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
CA2713765A1 (en) * 2008-02-06 2009-08-13 Innov'ia Pulverulent composition and a process for preparing the same
KR101685031B1 (ko) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
CN103037902A (zh) 2010-03-29 2013-04-10 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
EP2468265A3 (en) * 2010-12-04 2013-01-02 DEEF Pharmaceutical Industries Co. Homogeneous preparations containing vitamin D
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
CN104800185B (zh) * 2015-04-22 2018-03-09 青岛正大海尔制药有限公司 阿法骨化醇缓释片及其制备方法
EP4596045A3 (en) 2016-03-28 2025-10-15 EirGen Pharma Ltd. Methods of vitamin d treatment
WO2018124260A1 (ja) * 2016-12-28 2018-07-05 中外製薬株式会社 Ｅｄ－７１の固体分散体および油分分散体を含む医薬組成物
WO2020044314A1 (en) * 2018-08-31 2020-03-05 Opko Ireland Global Holdings, Ltd. Vitamin d pediatric dosage forms, methods of making and using

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2691619A (en) * 1951-09-18 1954-10-12 Pfizer & Co C Fat-soluble vitamin-containing products and process therefor
GB799068A (en) * 1955-12-29 1958-07-30 Hoffmann La Roche A stabilized vitamin-d composition and a process for the production thereof
GB1027675A (en) * 1963-01-07 1966-04-27 Henry Joseph Johnson Fortifying composition for water-base liquid food products
DE1492034A1 (de) * 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
GB1142147A (en) * 1965-05-28 1969-02-05 Glaxo Lab Ltd A process for making free-flowing gel particles
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
US3957966A (en) * 1972-05-19 1976-05-18 Gaf Corporation Stabilized vitamin food coatings
US3826823A (en) * 1972-09-25 1974-07-30 Syntex Inc Stabilized prostaglandin preparations
JPS5418330B2 (2) * 1973-03-16 1979-07-06
JPS58401B2 (ja) * 1974-07-15 1983-01-06 明治製菓株式会社 ケイコウヨウイヤクヒンソセイブツノ セイホウ
JPS5225015A (en) * 1975-08-22 1977-02-24 Sumitomo Chem Co Ltd Process for preparing fine granular drugs
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
FR2389377A1 (en) * 1977-05-06 1978-12-01 Brohult Johan Antiinflammatory, antirheumatic medicament - comprises 1 alpha-hydroxy-cholecalciferol
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS54135218A (en) * 1978-04-11 1979-10-20 Yamanouchi Pharmaceut Co Ltd Composition containing prostaglandin e
JPS5569562A (en) * 1978-11-21 1980-05-26 Teijin Ltd Stabilization of active vitamin d3 derivative
US4195078A (en) * 1979-03-09 1980-03-25 Eli Lilly And Company Nabilone granulation
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
US4301146A (en) * 1980-07-29 1981-11-17 G. D. Searle & Co. Stabilization of 16-oxygenated prostanoic acid derivatives
NZ203251A (en) * 1982-02-12 1986-04-11 Hoffmann La Roche Pharmaceutical compositions containing 1alpha,25,26-trihydroxycholecalciferol

Also Published As

Publication number Publication date
KR880001095B1 (ko) 1988-06-29
JPS59155309A (ja) 1984-09-04
JPS6360007B2 (2) 1988-11-22
EP0116755A1 (en) 1984-08-29
KR850000238A (ko) 1985-02-26
DE3372845D1 (en) 1987-09-10
HK86588A (en) 1988-11-04
US4729895A (en) 1988-03-08
EP0116755B1 (en) 1987-08-05

Similar Documents

Publication Publication Date Title
ATE37028T1 (de) Cephalosporinverbindungen, ihre herstellung, pharmazeutische praeparate und eingangsprodukte.
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
AR243515A1 (es) Un procedimiento para la obtencion de derivados de tiazol activos sobre el sistema colinergico.
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
NO170125C (no) Fremgangsmaate for fremstilling av lagringsstabile, hurtigopploeselige, farmasoeytiske virkestoff-presslegemer
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL88900A0 (en) Imidazoles,their preparation and pharmaceutical compositions containing them
IL67572A (en) Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them
HU9501623D0 (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an antidepressant drug
HUT42447A (en) Process for preparing novel benzol derivatives and pharmaceutical compositions comprising the same as active substance
AU8245087A (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
HUT53363A (en) Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
CA2100126A1 (en) 5,10-Methylenetetrahydrofolic Acid-Cyclodextrin Inclusion Compounds
AU2923389A (en) A pharmaceutical composition
MY104937A (en) Cephalosporin derivatives and processes for their preparation
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
IL66277A (en) 3,7-dialkyl-3,7-diazabicyclo(3.3.1)nonan-9-ol derivatives,a process for the preparation thereof and pharmaceutical compositions containing them
DE3070073D1 (en) 1,2,4-triazole derivatives, processes for their production and pharmaceutical compositions containing them
ZA918282B (en) Derivatives of(p.substituted phenyl)oxybutane amines,their processes of production and the pharmaceutical compositions containing them
HUT48613A (en) Process for producing carbamoyloxylabdane derivatives, their intermediaries and pharmaceutical compositions comprising such compounds as active ingredient
PT80961B (en) Process for the preparation of new pharmaceutical compounds containing mixtures of 4,9-dihydro-4-(1-methyl-4-piperydilene)-10h-benzoý4,5¨-cycloheptaý1,2-b¨thyophene-10-one and antiasthmati c xantines as active ingredient
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient